Please login to the form below

Not currently logged in
Email:
Password:

PhRMA appoints new EVP of public affairs

The Pharmaceutical Research and Manufacturers of America has appointed Josephine Martin as executive vice president, public affairs
The Pharmaceutical Research and Manufacturers of America (PhRMA) has appointed Josephine Martin as executive vice president, public affairs, reporting to PhRMA president and CEO John J Castellani, with effect from March 1, 2011. 

Martin, former senior vice president of public affairs at Ketchum, will be responsible for leading and managing PhRMA's communications and alliance development functions. 

Before joining Ketchum, Martin held leading public affairs positions at Golin Harris and National Media, Inc. Her health policy communications experience was developed earlier in her career as senior vice president, public affairs for the Federation of American Hospitals, and vice president of communications at the American Red Cross.

"We are thrilled to have Josie join our team at PhRMA. She brings extensive and successful experience in DC public affairs – with a particular strength in health policy communications," Castellani said. 

Commenting on her appointment, Martin said: "There are few, if any, American industries that positively impact people's lives in so many ways -- from improving health and productivity to providing good jobs, to strengthening local and national economies – as the biopharmaceutical sector." 

"I am excited to join such an energised, impactful organisation as PhRMA, and I relish the chance to bring my experience to bear as we work to best convey the tremendous value of this innovative sector," she continued.

7th February 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics